Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 16 Feb 2023
Many physicians have encountered one or more serious or potentially dangerous patients over the years, and according to Medscape research, patient trust has declined.
Read Full NewsThe HCPFive: Top News for Healthcare Providers from the Week of 10/25
Q&A: Asthma Remission from Year 1 To Year 2 With Depemokimab
A secondary analysis found the SWIFT accelerated protocol eased suicidal ideation faster than standard daily deep TMS dosing in major depressive disorder.
Interim phase 1b/2a data showed all patients treated with high- or low-dose BB-301 for oculopharyngeal muscular dystrophy met formal response criteria.
Here's some of what is coming soon to NeurologyLive® this week.
Jeffrey Cohen, MD, professor of neurology and staff physician at the Cleveland Clinic Mellen Center for Multiple Sclerosis, discusses interim BREAKFREE-2 findings for zola-cel, a CD19-directed CAR T cell therapy, in relapsing and progressive MS.
ASN Kidney Week 2026 Recap: 8 Key Updates in Kidney Disease to Know
1.
Schizophrenia patients are motivated by music therapy.
2.
Pediatric high-grade gliomas: Research reveals effective targeting with avapritinib
3.
Cancer deaths expected to rise to over 18 million in 2050, nearly 75% more than in 2024
4.
Breast Cancer Genetic Testing Need in Black Women Identified
5.
Products for Intimate Care and Cancer; Boost for Colorectal Cancer Stool Tests; Ultrasonic Biopsy?
1.
Clonal Hematopoiesis and Healthy Aging: Clinical Implications, Mechanisms, and Emerging Perspectives
2.
Understanding Sideroblastic Anemia and its Symptoms
3.
Targeted Degradation in Leukemia: Mechanisms, Clinical Implications, and Therapeutic Advances
4.
Age-Dependent Megakaryocyte Development: Mechanisms, Clinical Implications, and Future Directions
5.
Unlocking the Potential of Trabectedin: A Novel Therapy for Cancer Treatment
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
2.
First-Line Maintenance Therapy for Metastatic Urothelial Carcinoma: Bridging Clinical Practice and Trials
3.
Common Cancer Myths Debunked
4.
Blood Clotting Disorders Explained
5.
Understanding Blood Clotting Disorders
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge